PROCYON CORPORATION

PCYN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018 FY2017
Assets
Cash & Equivalents $290.3K $270.3K $173.2K
Accounts Receivable $512.9K $494.0K $407.1K $497.4K $311.0K $419.6K $372.3K $391.5K
Inventory $510.0K $431.4K $761.7K $591.1K $758.5K $485.4K $416.6K $506.7K
Total Current Assets $2.4M $2.2M $2.6M $2.9M $2.1M $1.6M $1.4M $1.3M
Property, Plant & Equipment $262.0K $281.0K $153.7K $109.3K $452.9K $488.5K $512.4K $513.8K
Goodwill
Intangible Assets (Excl. Goodwill) $17.0K $17.0K $17.0K $17.0K $17.0K $17.0K $17.0K $17.0K
Total Assets $3.2M $3.6M $3.8M $4.3M $2.8M $2.4M $2.4M $2.7M
Liabilities
Accounts Payable $160.9K $175.1K $178.1K $167.6K $167.5K $147.4K $95.5K $120.6K
Total Current Liabilities $769.2K $626.1K $643.2K $735.6K $514.0K $375.9K $326.5K $440.2K
Long-Term Debt
Total Liabilities $917.1K $946.0K $1.1M $1.4M $657.9K $375.9K $326.5K $442.3K
Stockholders' Equity
Retained Earnings $-2.3M $-2.0M $-1.9M $-1.7M $-2.4M $-2.5M $-2.6M $-2.3M
Total Stockholders' Equity $2.3M $2.4M $2.6M $2.9M $2.5M $2.1M $2.1M $1.9M
← Newer Page 1 of 2 Older →